<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04540328</url>
  </required_header>
  <id_info>
    <org_study_id>2015 / 029</org_study_id>
    <nct_id>NCT04540328</nct_id>
  </id_info>
  <brief_title>Non-surgical Peridontal Treatment on Cardiovascular Risk Markers</brief_title>
  <official_title>Effect of Non-surgical Peridontal Treatment on Cardiovascular Risk Markers in Patients With Severe Chronic Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kırıkkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kırıkkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the influence of non-surgical mechanical periodontal treatment in&#xD;
      patients with severe chronic periodontitis on inflammatory markers related to risk for&#xD;
      cardiovascular diseases&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 80 non-smokers with systemically healthy, including 40 patients with severe&#xD;
      chronic periodontitis and 40 periodontally health subjects were included into the present&#xD;
      study. The probing depth, clinical attachment level, plaque index, gingival index and blood&#xD;
      samples were collected at baseline and at the 3rd months after treatment and the serum levels&#xD;
      of asymmetric dimethylarginine (ADMA), endothelial nitric oxide synthase (eNOS), homocysteine&#xD;
      (Hcy), monocyte chemoattractant protein-1 (MCP-1) were determined with enzyme-linked&#xD;
      immunosorbent assay (ELISA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asymmetric dimethylarginine (ADMA)</measure>
    <time_frame>At the 3rd months after non-surgical periodontal treatment</time_frame>
    <description>Serum Concentration (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial nitric oxide synthase (eNOS)</measure>
    <time_frame>At the 3rd months after non-surgical periodontal treatment</time_frame>
    <description>Serum Concentration (pg/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Homocysteine (Hcy)</measure>
    <time_frame>At the 3rd months after non-surgical periodontal treatment</time_frame>
    <description>Serum Concentration (nmol/mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monocyte chemoattractant protein-1 (MCP-1)</measure>
    <time_frame>At the 3rd months after non-surgical periodontal treatment</time_frame>
    <description>Serum Concentration (ng/mL)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical periodontal parameter</measure>
    <time_frame>At the 3rd months after non-surgical periodontal treatment</time_frame>
    <description>Clinical attachment level (mm)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Cardiovascular Risk Markers</condition>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Non-surgical peridontal treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with chronic periodontitis received non-surgical periodontal treatment, including scaling and root planing and polishing within 14 days under local anesthesia with manual and ultrasonic devices and standardized oral hygiene instructions including methods of tooth-brushing and interdental cleaning were also given to each one. A professional supragingival plaque control was applied on a regular basis every month.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-surgical periodontal treatment</intervention_name>
    <arm_group_label>Non-surgical peridontal treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Clinical diagnosis of severe chronic periodontitis&#xD;
&#xD;
        Clinical diagnosis of periodontal health&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Systemic diseases such as diabetes, cardiovascular disease&#xD;
&#xD;
        Periodontal treatment within the previous year&#xD;
&#xD;
        Drugs such as systemic steroids, non-steroidal anti-inflammatory drugs, immunosuppressants,&#xD;
        hormone drugs, contraceptives, anticoagulants, cholesterol regulating drugs, systemic&#xD;
        antibiotics, antioxidants within the previous 3 months&#xD;
&#xD;
        Pregnant or lactating&#xD;
&#xD;
        Consumed alcohol&#xD;
&#xD;
        Smoker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>54 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 7, 2018</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kırıkkale University</investigator_affiliation>
    <investigator_full_name>Meltem Karsiyaka Hendek</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>asymmetric dimethylarginine</keyword>
  <keyword>endothelial nitric oxide synthase</keyword>
  <keyword>homocysteine</keyword>
  <keyword>monocyte chemoattractant protein-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

